Lisata Therapeutics's total assets for Q3 2024 were $38.20M, a decrease of -10.27% from the previous quarter. LSTA total liabilities were $4.76M for the fiscal quarter, a 4.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.